ACET — Adicet Bio Inc
Adicet Bio Inc (ACET) is listed on NASDAQ.
ACET belongs to the HEALTHCARE sector and the BIOTECHNOLOGY industry.
To answer "what is ACET worth" or "what is happening with Adicet Bio Inc", VAQO shows a live price alongside technical analysis, relevant headlines and what other investors think.
VAQO's learning model reads seven technical indicators — short and long momentum, RSI, volatility, volume ratio, moving-average cross and position in the 52-week range — and turns them into transparent opportunity and risk scores.
What ACET is
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company is headquartered in Boston, Massachusetts.…
Adicet Bio Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ACET size and valuation
At roughly $58.5M, ACET is a micro-cap.
Earnings per share are negative at -10.21, so there is no meaningful price-to-earnings multiple to quote.
Beta is 1.63: historically it has moved more than the market.
ACET over the past year
Over the past year ACET has traded between $6.01 and $17.44, and the current price sits at -26% of that range.
Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.
The 50-day average is $8.64 against a 200-day average of $8.01 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $34.83, 1,042.0% above it. A target is an aggregate of opinions, not a measurement.
How Adicet Bio Inc (ACET) is trading
Adicet Bio Inc (ACET) is up 4.45% at $3.05 — a more volatile session than average.
The session ranged from $2.89 to $3.14 — 8.3% of the share price — and the current price sits at 63% of that range.
Volume ran near 254.1K shares, about $774.9K of stock changing hands.
Traded alongside ACET
Names traded alongside ACET in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ACET
Two statistical models run over ACET inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
ACET at a glance
- Symbol: ACET
- Name: Adicet Bio Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ACET — frequently asked questions
What is the market cap of ACET?
Adicet Bio Inc has a market capitalisation of roughly $58.5M.
What is the 52-week range for ACET?
ACET has traded between $6.01 and $17.44 over the past year, with the current price at -26% of that range.
How much does ACET stock cost today?
Adicet Bio Inc (ACET) trades at $3.05, a change of +4.45% in the latest session.
Is ACET up or down today?
ACET is up 4.45% in the latest session, at $3.05.
What is the daily trading range for ACET?
ACET traded between $2.89 and $3.14 in the latest session, and currently trades at $3.05.
What is the trading volume for ACET?
ACET traded roughly 254.1K shares in the latest session.
Which exchange is ACET listed on?
ACET is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ACET stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ACET figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Traded alongside ACET
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08